WAY-207024

N/A

Report date: 2022/07/01 15:29:28

NME

Base Information

Drug NameWAY-207024

Drug Alias NameWAY-207024

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionGonadotropin-releasing hormone receptor agonists

TargetsGonadotropin-releasing hormone receptor

Therapy Area/IndicationsUterine Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsUterine Neoplasms

ATC CodeN/A